Search Results - "Sehdev, S."

Toward Green Communication in 6G-Enabled Massive Internet of Things by Verma, Sandeep, Kaur, Satnam, Khan, Mohammad Ayoub, S. Sehdev, Paramjit

“…The sixth generation (6G) is envisioned to be a spawned key technology that will support the ubiquitous and seamless connection of a massive number of…”
Get full text

A randomized trial of individualized versus standard of care antiemetic therapy for breast cancer patients at high risk for chemotherapy-induced nausea and vomiting by Clemons, M., Dranitsaris, G., Sienkiewicz, M., Sehdev, S., Ng, T., Robinson, A., Mates, M., Hsu, T., McGee, S., Freedman, O., Kumar, V., Fergusson, D., Hutton, B., Vandermeer, L., Hilton, J.

“…Despite triple antiemetic therapy use for breast cancer patients receiving emetogenic chemotherapy, nausea remains a clinical challenge. We evaluated adding…”
Get full text

Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized trial by Mackey, J.R., Pieńkowski, T., Crown, J., Sadeghi, S., Martin, M., Chan, A., Saleh, M., Sehdev, S., Provencher, L., Semiglazov, V., Press, M.F., Sauter, G., Lindsay, M., Houé, V., Buyse, M., Drevot, P., Hitier, S., Bensfia, S., Eiermann, W.

“…The optimal regimen for adjuvant breast cancer chemotherapy is undefined. We compared sequential to concurrent combination of doxorubicin and cyclophosphamide…”
Get full text

P021 A pragmatic randomised, multicentre trial evaluating the dose timing (morning vs evening) of endocrine therapy for early breast cancer (REaCT-CHRONO Study) by Savard, M.-F., Ibrahim, M., Pond, G.R., Saunders, D., Vandermeer, L., Fallowfield, L.J., Ng, T.L., Awan, A.A., Sehdev, S., Beltran-Bless, A.A., Clemons, M.

Get full text

The Origin of Quarantine by Mackowiak, Philip A., Sehdev, Paul S.

Get full text

Dementia patients have greater anti-cholinergic drug burden on discharge from hospital: A multicentre cross-sectional study by Randall, J., Hook, A., Grubb, C-M., Ellis, N., Wellington, J., Hemmad, A., Zerdelis, A., Geers, B., Sykes, B., Auty, C., Vinchenzo, C., Thorburn, C., Asogbon, D., Granger, E., Boagey, H., Raphael, J., Patel, K., Bhargava, K., Dolley, M.-K., Maden, M., Shah, M., Lee, Q., Vaidya, R., Sehdev, S., Barai, S., Roche, S., Khalid, U., Harrison, J., Codling, D.

“…Introduction Anticholinergic medications block cholinergic transmission. The central effects of anticholinergic drugs can be particularly marked in patients…”
Get full text

Impact of Trimethoprim-Sulfamethoxazole Prophylaxis on Falciparum Malaria Infection and Disease by Thera, Mahamadou A., Sehdev, Paul S., Coulibaly, Drissa, Traore, Karim, Garba, Mamane N., Cissoko, Yacouba, Kone, Abdoulaye, Guindo, Ando, Dicko, Alassane, Beavogui, Abdoul H., Djimde, Abdoulaye A., Lyke, Kirsten E., Diallo, Dapa A., Doumbo, Ogobara K., Plowe, Christopher V.

“…BackgroundTrimethoprim-sulfamethoxazole (TS) prophylaxis is recommended for persons living with human immunodeficiency virus infection and acquired…”
Get full text

Dynamics of polymorphism in a malaria vaccine antigen at a vaccine-testing site in Mali by Takala, Shannon L, Coulibaly, Drissa, Thera, Mahamadou A, Dicko, Alassane, Smith, David L, Guindo, Ando B, Kone, Abdoulaye K, Traore, Karim, Ouattara, Amed, Djimde, Abdoulaye A, Sehdev, Paul S, Lyke, Kirsten E, Diallo, Dapa A, Doumbo, Ogobara K, Plowe, Christopher V

“…Malaria vaccines based on the 19-kDa region of merozoite surface protein 1 (MSP-1(19)) derived from the 3D7 strain of Plasmodium falciparum are being tested in…”
Get full text

Patient adherence to aromatase inhibitor treatment in the adjuvant setting by Verma, S, Madarnas, Y, Sehdev, S, Martin, G, Bajcar, J

“…Improvements in adjuvant systemic therapy and detection of early disease have resulted in a decline of breast cancer death rates across all patient age groups…”
Get full text

Noninvasive and invasive micropapillary (low-grade) serous carcinoma of the ovary: A clinicopathologic analysis of 135 cases by SMITH SEHDEV, Ann E, SEHDEV, Paul S, KURMAN, Robert J

“…Reports describing the behavior of micropapillary serous carcinomas (MPSCs) of the ovary have focused on those that are noninvasive. There are only very…”
Get full text

Models of care for early-stage breast cancer in Canada by Madarnas, Y, Joy, A A, Verma, S, Sehdev, S, Lam, W, Sideris, L

“…There is growing evidence that follow-up for patients with early breast cancer (ebc) can be effectively carried out by the primary health care provider if a…”
Get full text

Safety of adjuvant endocrine therapies in hormone receptor-positive early breast cancer by Sehdev, S, Martin, G, Sideris, L, Lam, W, Brisson, S

“…Postmenopausal patients with hormone-sensitive early breast cancer are typically treated with adjuvant endocrine therapy, which significantly reduces the risk…”
Get full text

Cancer therapy disparity: unequal access to breast cancer therapeutics and drug funding in Canada by Verma, S, Sehdev, S, Joy, A A

“…Adjuvant therapy has made a significant contribution in reducing breast cancer-specific mortality. Standard chemotherapeutics and tamoxifen have been the…”
Get full text

Human Monocytic Ehrlichiosis Presenting as Acute Appendicitis During Pregnancy by Smith Sehdev, Ann E., Sehdev, Paul S., Jacobs, Ruth, Dumler, J. Stephen

“…Human monocytic ehrlichiosis (HME) is caused by Ehrlichia chaffeensis, an obligate intracellular bacterium that infects mononuclear phagocytic cells. We report…”
Get full text

An updated review on the efficacy of adjuvant endocrine therapies in hormone receptor-positive early breast cancer by Verma, S, Sehdev, S, Joy, A, Madarnas, Y, Younus, J, Roy, J A

“…The third-generation aromatase inhibitors (AIS) are largely replacing tamoxifen in the adjuvant treatment of early-stage breast cancer in postmenopausal women…”
Get full text

416P Cost-effectiveness of first-line (1L) ribociclib use vs palbociclib in the treatment of postmenopausal women with HR+/HER2− advanced breast cancer (ABC): Analysis based on final overall survival (OS) results of MONALEESA-2 (ML-2) and PALOMA-2 (PAL-2) by Sehdev, S., Brezden-Masley, C., Soliman, D., El Ouagari, K., Biswas, C., Kalra, M., Sharma, V.

Get full text

EE317 Cost-Effectiveness of Adjuvant Olaparib in Germline BRCA1/2-Mutated, High-Risk, Human Epidermal Growth Factor-2-Negative Early Breast Cancer: A Canadian Perspective by Parackal, A, Ting, E, Verhoek, A, Joy, A, Sehdev, S, Hettle, R

Get full text

Atovaquone/proguanil for plasmodium falciparum malaria by Sehdev, Paul S

Get full text

Ketamine for rapid sequence induction in patients with head injury in the emergency department by Sehdev, Rajesh S, Symmons, David AD, Kindl, Korana

“…Objective:  To examine the evidence regarding the use of ketamine for induction of anaesthesia in patients with head injury in the ED. Method:  A literature…”
Get full text

Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication by Schneeweiss, A., Peretz-Yablonski, T., Nowecki, Z., Merot, J.-L., Pena-Murillo, C., Bachelot, T., Coudert, B., Nowecki, Z., Wardley, A., Puglisi, F., Montemurro, F., Hu, X., Gaafar, R., Li, H., Aktas, B., Tienghi, A., Miles, D., Lux, M., Menjon Beltran, S., Turner, N., Tong, Z., Boer, K., Horvath, Z., Susnjar, S., Matos, E., Garcia Estevez, L., Cruz, M., Bourgeois, H., von Schumann, R., Morales-Vásques, F., Voitko, N., Hicks, J., Barrett-Lee, P., Wheatley, D., Gozy, M., Latini, L., Barnadas Molins, A., Bratos, R., McCarthy, N., Kee, D., Artignan, X., Azribi, F., Jaafar, H., Augereau, P., Müller, V., Evron, E., Cascinu, S., El-Saghir, N., Ghosn, M., Oosterkamp, H.M., Kukulska, M., Levitt, N., Panwar, U., Rigg, A., Fein, L., Malik, L., Singer, C., Stoeger, H., Cedeño, M., Berdah, J.-F., Goncalves, A., Orfeuvre, H., Fried, G., Moscetti, L., Siddiqi, N., Arcediano Del Amo, A., McAdam, K., Dunn, G., Taylor, W., Hegg, R., Grosjean, J., Laplaige, P., Christensen, B., Zahm, D.-M., Inbar, M., Bonetti, A., van der Velden, A., van Warmerdam, L., Viñas Vilaro, G., Bachmeier, K., Beresford, M., Joffe, J., Nobre, A., Jiang, J., Padrik, P., Dohollou, N., Prulhiere, K., Ober, A., Alabiso, O., van de Wouw, A.J., Saadein, A., Abdelhafiez, N., Abulkhair, O., Llorente Domenech, R., Gil Raga, M., Rodriguez Sanchez, C., Torrego Garcia, J., Vicente Rubio, E., Jones, A., Alonso, I.

“…The phase III CLinical Evaluation Of Pertuzumab And TRAstuzumab (CLEOPATRA) trial established the combination of pertuzumab, trastuzumab and docetaxel as…”
Get full text